CCM International Limited, April 2010, Pages: 178
category of red biotechnologies, with key influencing factors and commercial opportunities
- Profiles of major players and research institutes
- Related policies and regulations
What benefits will you
TriMark Publications, Sep 2010, Pages: 288
in Regenerative Medicine
5.1.3 Current Model for Autologous Cell Therapies
5.1.4 Current Models for Allogeneic Cell Therapies
5.1.5 Key Factors for Successful Business Models for Cell Therapies
5.2 Commercial
Knowledge Press, March 2004, Pages: 450
of materials and fabrication technologies. With these advancements in lab research, Mems technology is now poised to deliver commercial opportunities with innovative applications. However, a roadmap
